Large gap with delayed quotes
|
Last quote
09/11/2026
-
17:30:17
|
Bid
09/11/2026 -
19:04:30
|
Bid Volume |
Ask
09/11/2026 -
17:40:00
|
Ask Volume |
|---|---|---|---|---|
|
8.69
-0.11
(
-1.25% )
|
8.58
|
116 |
9.03
|
5,000 |
Analysis date: 08.09.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 31.07.2026.
Interest
Very strong
Very strong
Four stars since 31.07.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 24.07.2026 at a price of 8.19.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 31.07.2026.
4wk Rel Perf
-0.03%
-0.03%
The four-week dividend-adjusted performance versus STOXX600 is .
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 25.08.2026.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.47%.
Mkt Cap in $bn
0.46
0.46
With a market capitalization <$2bn, MEDMIX AG is considered a small-cap stock.
G/PE Ratio
1.89
1.89
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
10.26
10.26
The estimated PE is for the year 2028.
LT Growth
15.34%
15.34%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
4
4
Over the last seven weeks, an average of 4 analysts provided earnings per share estimates.
Dividend Yield
4.03%
4.03%
The twelve month estimated dividend yield represents 41.38% of earnings forecasts.
Beta
79
79
For 1% of index variation, the stock varies on average by 0.79%.
Correlation
0.28
0.28
Stock movements are strongly independent of index variations.
Value at Risk
1.85
1.85
The value at risk is estimated at CHF 1.85. The risk is therefore 20.59%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
21.10.2022
21.10.2022